After a Bucks teen died of osteosarcoma, his grandparents donated $6.4M to CHOP


When 18-year-old Connor Boyle was dying of a uncommon bone most cancers, his mother and father requested his final needs.

“I don’t wish to see one other child endure via most cancers,” he replied. He died from osteosarcoma in August 2022 — the identical day that the Bucks County teen was supposed to maneuver right into a freshman dorm at Villanova College, the place he had been accepted into its enterprise college.

Earlier this month, Boyle’s grandparents, David and Patricia Holveck, gifted $6.4 million to the Youngsters’s Hospital of Philadelphia to fund analysis to seek out higher therapies for pediatric sufferers with osteosarcoma.

“That is hopefully a primary step towards making Connor’s dream occur,” his father, Matthew Boyle, stated in an interview.

What’s osteosarcoma?

Osteosarcoma, the most typical cancerous bone tumor in kids and younger adults, impacts about 400 kids annually nationwide. It usually happens throughout essential development intervals, comparable to puberty, and is usually identified after ache and swelling happens on the bone tumor’s website.

Tumors generally begin on the femur, or lengthy thigh bone above the knee, however may be laborious to deal with as a result of every bone tumor is exclusive, requiring tailor-made therapy. Additionally, the illness can rapidly unfold to different organs or physique tissues, usually within the lungs. Its rarity means medical doctors and researchers haven’t studied it almost as a lot as extra widespread grownup cancers and funding is scarce.

For that reason, therapy for osteosarcoma hasn’t modified a lot prior to now 30 years, based on Theodore Laetsch, a pediatric oncologist who heads CHOP’s Very Uncommon Malignant Tumors Program. Sometimes, the diseased bone is surgically eliminated, and the affected person then goes via intense chemotherapy for about six months.

About 70% of these sufferers are cured. But when the illness spreads, prefer it did in Connor Boyle’s case, solely 1 / 4 of sufferers will survive.

The trail to a dying want

The three-year, multimillion-dollar reward — named “The Connor Initiative: Precision Therapeutics for Osteosarcoma & Uncommon Cancers” — will probably be used to advance research on new drug therapies and assist households discover their method to the absolute best care expertise. It’ll fund initiatives to:

  1. Present sufferers and their households with a nurse navigator, who will assist coordinate appointments to chop down on visits to CHOP for chemotherapy, radiation and different therapies.

  2. Seize tumor tissue from sufferers and research the genetic make-up of every tumor. The information will probably be used to find out which medication work greatest in opposition to osteosarcoma and different uncommon pediatric cancers that share an identical genetic profile.

  3. Research most cancers cells and spearhead medical trials that result in new and higher therapies. For example, researchers plan to zero in on mitochondria, which generate a lot of the power wanted to energy cells. Laetsch described mitochondria because the “powerhouse” or “power manufacturing unit” in every cell, together with cancerous ones. Laetsch stated they hope to chop off that energy supply and kill off cancerous cells.

“The endgame is to establish medication and new therapies that may particularly assault osteosarcoma,” Laetsch stated. “That is fairly some huge cash and we predict it will likely be transformative for these sufferers and their households.”

A decided younger man

The reward will honor the legacy of Connor Boyle, who was identified with osteosarcoma at age 15 at the beginning of his sophomore yr in highschool. His father remembers the precise date: Sept. 28, 2019. Connor had hit puberty. At 6 toes 5 inches tall, he performed baseball, basketball and soccer at Central Bucks East Excessive Faculty.

“You’d ask him what his favourite sport was and it was at all times no matter season it was — that’s what his favourite sport was,” Matthew Boyle stated. “He was a coach’s dream. The coach would give instruction and he would sit and pay attention after which do it.”

On that September morning, he felt out of breath whereas warming up for a soccer sport in school.

His mother and father took him to Doylestown Hospital, the place he was identified with a collapsed lung. The situation was unrelated to most cancers, however whereas speaking to the ER physician, Boyle’s mother and father talked about a swollen bump on his proper femur.

An X-ray revealed a tumor. He had by no means complained of any ache.

“Truthfully, we simply thought it was an harm from soccer,” his father recalled.

An ambulance crew transported him to CHOP that night time. It will be the primary of 102 nights he spent there over three years of therapy.

His therapy began when a surgeon eliminated the tumor and changed the diseased femur with a 12-inch rod, adopted by six rounds of chemotherapy, his father recalled.

Connor continued to play sports activities throughout his junior yr, together with on his highschool’s JV baseball crew. He pitched from the mound on a synthetic leg.

However the illness had unfold to his chest.

In all, he underwent a dozen surgical procedures to take away cancerous growths from his lungs and chest. He additionally acquired a number of rounds of chemotherapy, every of which required him to remain at CHOP for 2 days.

He didn’t wish to miss college so he requested if he may do the therapy on weekends. His oncologist stated he was the primary affected person to ever make that request, his father stated.

He maintained straight A’s and bought accepted into Villanova.

On his June 2022 commencement day, he awoke early and bought to CHOP at about 7 a.m. for his fifteenth spherical of radiation.

It will be his final. He died about two months later.

“He simply wished to be regular. He wished to be current,” Matthew Boyle stated.

Hot Topics

Related Articles